| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2014 | US20140018415 Enhancing Autophagy or Increasing Longevity by Administration of Urolithins or Precursors Thereof |
| 01/16/2014 | US20140018414 Methods of inducing anesthesia |
| 01/16/2014 | US20140018406 Treatment of Chronic Obstructive Pulmonary Disease With Nebulized Beta 2-Agonist or Combined Nebulized Beta 2-Agonist and Anticholinergic Administration |
| 01/16/2014 | US20140018403 No-releasing guanidine-coxib anti-cancer agents |
| 01/16/2014 | US20140018402 Pharmaceutical composition for preventing or treating macular degeneration |
| 01/16/2014 | US20140018400 Methods and compositions related to neuroactive thiazoline compounds |
| 01/16/2014 | US20140018398 Otamixaban formulations with improved stability |
| 01/16/2014 | US20140018397 Sustained Release Aminopyridine Composition |
| 01/16/2014 | US20140018396 Combination of sulfonamide compound |
| 01/16/2014 | US20140018395 Controlled Release Auris Sensory Cell Modulator Compositions and Methods for the Treatment of Otic Disorders |
| 01/16/2014 | US20140018392 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 01/16/2014 | US20140018387 Ointment with excellent formulation stability |
| 01/16/2014 | US20140018386 Laquinimod formulations without alkalizing agent |
| 01/16/2014 | US20140018385 Identification Of PCNA Targeting Compounds For Cancer Therapy And PCNA Function Regulation |
| 01/16/2014 | US20140018384 Quinolinone derivatives for use in the treatment of an autoimmune disease and/or an inflammatory disease |
| 01/16/2014 | US20140018383 Myeloid differentiation inducing agents |
| 01/16/2014 | US20140018382 Method for treament of neurologic dysfunction |
| 01/16/2014 | US20140018374 Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors |
| 01/16/2014 | US20140018372 Crystalline form of a indolinone derivative and its use |
| 01/16/2014 | US20140018371 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| 01/16/2014 | US20140018369 Controlled release sterile injectable aripiprazole formulation and method |
| 01/16/2014 | US20140018362 Methods of treatment of opioid tolerance, physical dependence, pain, and addiction with inhibitors of certain growth factor receptors |
| 01/16/2014 | US20140018360 Azaindenoisoquinoline topoisomerase i inhibitors |
| 01/16/2014 | US20140018355 Lisofylline analogs and methods for use |
| 01/16/2014 | US20140018354 Inhibitors of mtor kinase as anti-viral agents |
| 01/16/2014 | US20140018353 Method of treating b-cell malignant cancers and t-cell malignant cancers using thienotriazolodiazepine compounds |
| 01/16/2014 | US20140018352 Compounds useful as protein kinase inhibitors |
| 01/16/2014 | US20140018350 Combination of sulfonamide compound and tafluprost |
| 01/16/2014 | US20140018349 Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder |
| 01/16/2014 | US20140018348 Composition and Method for Treatment of Depression and Psychosis in Humans |
| 01/16/2014 | US20140018346 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer |
| 01/16/2014 | US20140018344 Azaindole derivatives |
| 01/16/2014 | US20140018342 Gamma secretase inhibitors |
| 01/16/2014 | US20140018339 Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein |
| 01/16/2014 | US20140018338 Methods and assays for treating filoviridae infections |
| 01/16/2014 | US20140018335 Indole derivative, and pharmacologically acceptable salt thereof |
| 01/16/2014 | US20140018334 Oral Dosage Forms of Bendamustine |
| 01/16/2014 | US20140018333 Dimer diol compositions as substitutes of body fluids |
| 01/16/2014 | US20140018332 Methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin d analog with or without a retinoid |
| 01/16/2014 | US20140018331 Methods for the treatment or prophylaxis of thrombosis or embolism |
| 01/16/2014 | US20140018330 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea |
| 01/16/2014 | US20140018329 Compositions and methods of use of phorbol esters in the treatment of neoplasms |
| 01/16/2014 | US20140018328 Clear, Greaseless Skin Care Compositions |
| 01/16/2014 | US20140018327 Pyrrole Derivatives as Nicotinic Acetylcholine Receptor Modulators for Use in the Treatment of Neurodegenerative Disorders Such as Alzheimer's and Parkinson's Disease |
| 01/16/2014 | US20140018326 Sulfonamides as hib protease inhibitors |
| 01/16/2014 | US20140018324 Method for improving tetracycline-resistance of acinetobacter baumannii |
| 01/16/2014 | US20140018321 Imidazole prodrug lxr modulators |
| 01/16/2014 | US20140018319 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 01/16/2014 | US20140018316 Ophthalmic pharmaceutical composition |
| 01/16/2014 | US20140018315 Dilute filtration sterilization process for viscoelastic biopolymers |
| 01/16/2014 | US20140018313 Antiviral compounds |
| 01/16/2014 | US20140018312 Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria |
| 01/16/2014 | US20140018311 Muscadine compositions with improved anti-oxidant activity |
| 01/16/2014 | US20140018310 COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY |
| 01/16/2014 | US20140018308 Methods of lowering blood pressure |
| 01/16/2014 | US20140018296 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 01/16/2014 | US20140018295 Nasal delivery |
| 01/16/2014 | US20140018293 Minimizing intestinal dysfunction |
| 01/16/2014 | US20140018287 Bridge-helix cap: target and method for inhibition of bacterial rna polymerase |
| 01/16/2014 | US20140017786 Small molecule inhibitors of replication protein a that also act synergistically with cisplatin |
| 01/16/2014 | US20140017774 Pca3, pca3 genes, and methods of use |
| 01/16/2014 | US20140017742 Preparation of microbial oil |
| 01/16/2014 | US20140017342 Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes |
| 01/16/2014 | US20140017341 Composition and method for treating fat tissues and inflammatory processes |
| 01/16/2014 | US20140017340 Skin external composition comprising a pure salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| 01/16/2014 | US20140017339 Materials and methods for treating radiation poisoning |
| 01/16/2014 | US20140017338 Compositions for and methods of contrlling olfactory responses to odorants |
| 01/16/2014 | US20140017336 Co-administration of arsenic compounds and anti-herpes virus anti-virals |
| 01/16/2014 | US20140017329 Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting |
| 01/16/2014 | US20140017328 Particle composition and pharmaceutical composition using particle composition |
| 01/16/2014 | US20140017327 System for Targeted Delivery of Therapeutic Agents |
| 01/16/2014 | US20140017324 Multiparticulate l-menthol formulations and related methods |
| 01/16/2014 | US20140017323 Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| 01/16/2014 | US20140017322 Supramolecular functionalization of graphitic nanoparticles for drug delivery |
| 01/16/2014 | US20140017321 Methods and medicaments for administration of ibuprofen |
| 01/16/2014 | US20140017317 Methods of treatment of solid tumors using coenzyme q10 |
| 01/16/2014 | US20140017316 Methods and compositions for treating recurrent cancer |
| 01/16/2014 | US20140017315 Methods and compositions for treeating proliferative diseases |
| 01/16/2014 | US20140017314 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 01/16/2014 | US20140017312 Multi-vitamin and Mineral Nutritional Supplements |
| 01/16/2014 | US20140017309 Enteral administration of sorbent polymer for treatment and prophylaxis of inflammation |
| 01/16/2014 | US20140017308 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin |
| 01/16/2014 | US20140017306 Stable pharmaceutical composition and methods of using same |
| 01/16/2014 | US20140017303 Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms |
| 01/16/2014 | US20140017300 Delivery of nucleic acid-like compounds |
| 01/16/2014 | US20140017299 Steroid hormone delivery systems and methods of preparing the same |
| 01/16/2014 | US20140017294 Infused Carbohydrate Based Gel Pad for Sustained Oral Transmucosal Delivery |
| 01/16/2014 | US20140017293 Compositions and methods for the sustained release of beta-alanine |
| 01/16/2014 | US20140017286 Pouch containing nicotine in free salt form |
| 01/16/2014 | US20140017282 Use of whey permeate for the treatment of metabolic syndrome |
| 01/16/2014 | US20140017279 Adjuvant nanoemulsions with crystallisation inhibitors |
| 01/16/2014 | US20140017277 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 01/16/2014 | US20140017273 Albumin-Fused Anti-Angiogenesis Peptides |
| 01/16/2014 | US20140017262 Cripto binding molecules |
| 01/16/2014 | US20140017261 Selection and treatment of subjects |
| 01/16/2014 | US20140017236 Methods for treating interleukin-6 related diseases |
| 01/16/2014 | US20140017230 Chronic lymphocytic leukemia (cll) biomarkers |
| 01/16/2014 | US20140017226 Treatment of multiple sclerosis with combination of laquinimod and fampridine |
| 01/16/2014 | US20140017222 Compositions and methods for the prevention of cardiovascular disease |
| 01/16/2014 | US20140017221 Superoxide Dismutase Variants and Methods of Use Thereof |